Interaction of fatty acids with recombinant rat intestinal and liver fatty acid-binding proteins by Nemecz, Gyorgy et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 
Vol. 286, No. 1, April, pp. 300-309, 1991 
Interaction of Fatty Acids with Recombinant Rat 
Intestinal and Liver Fatty Acid-Binding Proteins 
Gyorgy Nemecz, * Timothy Hubbell, * John R. Jefferson, * John B. Lowe,? and Friedhelm Schroeder*?’ 
*Division of Pharmacology and Medicinal Chemistry, Department of Pharmacology and Cell Biophysics, University of Cincinnati 
Medical Center, Cincinnati, Ohio 45267-0004; and f Department of Pathology and Laboratory Medicine and Howard Hughes 
Medical Institute, Medical Center, University of Michigan, Ann Arbor, Michigan 48105 
Received September 11,199O 
Intestinal enterocytes contain two homologous fatty 
acid-binding proteins, intestinal fatty acid-binding pro- 
tein (I-FABP)’ and liver fatty acid-binding protein (L- 
FABP) . Since the functional basis for this multiplicity is 
not known, the fatty acid-binding specificity of recom- 
binant forms of both rat I-FABP and rat L-FABP was 
examined. A systematic comparative analysis of the 1% 
carbon chain length fatty &id binding parameters, using 
both radiolabeled (stearic, oleic, and linoleic) and flu- 
orescent (tram-parinaric and cis-parinaric) fatty acids, 
was undertaken. Results obtained with a classical Lipi- 
dex-1000 binding assay, which requires separation of 
bound from free fatty acid, were confirmed with a flu- 
orescent fatty acid-binding assay not requiring separa- 
tion of bound and unbound ligand. Depending on the na- 
ture of the fatty acid ligand, I-FABP bound fatty acid 
had dissociation constants between 0.2 and 3.1 pM and a 
consistent 1: 1 molar ratio. The dissociation constants for 
L-FABP bound fatty acids ranged between 0.9 and 2.6 
pM and the protein bound up to 2 mol fatty acid per mole 
of protein. Both fatty acid-binding proteins exhibited 
relatively higher afllnity for unsaturated fatty acids as 
compared to saturated fatty acids of the same chain 
length. cis-Parinaric acid or trane-parinaric acid (each 
containing four double bonds) bound to L-FABP and I- 
FABP were displaced in a competitive manner by non- 
fluorescent fatty acid. Hill plots of the binding of cis- and 
trans- parinaric acid to L-FABP showed that the binding 
affinities of the two sites were very similar and did not 
exhibit cooperativity. The lack of fluorescence self- 
quenching upon binding 2 mol of either trans- or cis- 
parinaric acid/m01 L-FABP is consistent with the pres- 
ence of two binding sites with dissimilar orientation in 
the L-FABP. Thus, the difference in binding capacity be- 
tween I-FABP and L-FABP predicts a structurally dif- 
ferent binding site or sites. Q 1991 Academic PUSS, IW. 
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The fatty acid-binding proteins represent a class of hy- 
drophobic ligand binding proteins whose role in intra- 
cellular lipid trafficking ( 1) and in affecting gene expres- 
sion (2-6) is becoming an exciting area of focus. Their 
molecular biology ( 1,7,8), structure ( 9), and postulated 
function(s) ( 2, 10-12) have been extensively reviewed. 
These abundant proteins represent 3-6% of cell cytosol. 
However, their tissue distribution is not exclusive and, 
as shown for the intestinal enterocyte, multiple forms of 
fatty acid-binding proteins may be present in the same 
cell. The physiological significance of this multiplicity is 
unknown. Knowledge of the ligand specificity and of the 
structure of the fatty acid-binding site(s) of these proteins 
is important to understanding the role of the fatty acid- 
binding proteins in regulating lipid metabolism. Nev- 
ertheless, the tertiary structure of only one of these pro- 
teins, I-FABP, has been resolved (13) and comparative 
ligand-binding studies are few ( 14). 
A variety of techniques have been used to examine the 
fatty acid-binding properties of the FABP’s, possibly ex- 
plaining the variation in reported affinities and stoichi- 
ometries. For example, it is generally agreed that I-FABP 
has only one binding site (11, 13, 14). In contrast, the 
stoichiometry of fatty acid binding to L-FABP has been 
variously reported as 1:l (11, 15-19) or 2:l (9, 14, 20) 
and depends upon the physical state of the unbound fatty 
acid and the sample pH (21). 
This paper presents the results of a comparative study 
of the fatty acid-binding characteristics of the liver and 
intestinal FABPs using a series of 18 carbon chain length 
fatty acids. Recombinant fatty acid binding proteins were 
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used to avoid possible contamination with other mam- 
malian proteins. Two different fatty acid-binding methods 
were applied: (i) a classic method using 14C-radiolabeled 
fatty acid (Lipidex method), and (ii) a new fluorescent 
fatty acid-binding assay using naturally fluorescent fatty 
acids, cis- and trans-parinaric acid, that do not contain 
bulky side chain constituents. The binding affinity was 
further characterized by displacing the fluorescent fatty 
acids with nonfluorescent fatty acids to obtain more in- 
formation about the structural specificity of fatty acid 
binding. 
MATERIALS AND METHODS 
Materials. Lipidex-1000 was purchased from Packard Instrument 
Co. Inc. (Downers Grove, IL) and from Sigma Chemical Co. (St. Louis, 
MO). truns-Parinaric and cis-parinaric acids were obtained from Mo- 
lecular Probes (Eugene, OR). [1-i4C]stearic acid (55.3 mCi/mmol) was 
obtained from New England Nuclear, (Boston, MA). [ 9,10-3H( N)] - 
oleic acid (10 Ci/mmol), and [l-i4C]-linoleic acid (56 mCi/mmol) 
were obtained from Amersham Co. (Arlington Heights, IL). Stearic, 
oleic, and linoleic acid were obtained from Sigma Chemical Co. (St. 
Louis, MO). 
Protein purification. The recombinant fatty acid binding proteins 
were purified from E. coli host strains carrying plasmid pJBLZ encoding 
L-FABP or plasmid pIFABPexp6 encoding I-FABP using procedures 
identical to those described earlier by Lowe et al. ( 14). Purified FABPs 
were delipidated as described (14, 15) prior to use in binding studies. 
Purity of the proteins was determined by SDS-polyacrylamide gel elec- 
trophoresis also as described earlier ( 14). Protein concentration was 
determined hy Lowry (22) or Bradford (23) protein assays and corrected 
according to amino acid analysis. The Bradford protein assay overes- 
timates L-FABP 1.69-fold (14) and I-FABP 1.07-fold while the method 
of Lowry overestimates L-FABP and I-FABP 1.70-fold and 1.16.fold, 
respectively. 
Radiolabeled fatty acid binding. Purified delipidated FABPs were used 
in fatty acid-binding assays. The fatty acid-binding assay with Lipidex- 
1000 (15) was carried out as described by Lowe et al. (14) except that 
the incubation temperature of the samples was lowered to 25°C. In a 
total assay volume of 1 ml 10 mM potassium phosphate buffer (pH 7.4) 
the FABP concentration was varied between 0.26 and 0.40 pM. The 
assay mixture contained 40 ~1 (5 rCi/ml in 25% EtOH) labeled fatty 
acid, 960 ~1 buffer, with or without protein. Fatty acids were added to 
the assay tubes as 50% ethanol solutions such that the final concentration 
ranged from 0.1 to 10 pM. The final ethanol concentration was main- 
tained the same in each tube and did not exceed 1%. This level of ethanol 
was similar to that used in previous studies. After the incubation at 
25’C for 20 min the tubes were chilled on ice for 10 min. Continuously 
stirred Lipidex-1000 50% (v/v) buffer suspension (150 ~1) was added 
to the sample followed by vigorous stirring and incubation for 10 min 
at 4°C. The assay tubes were centrifuged at 10,OOOg for 4 min at 4°C. 
A 400.~1 aliquot of the supernatant was removed and subjected to scin- 
tillation counting using a LS 7000 (Beckman Inc, Fullerton, CA) scin- 
tillation counter. Blank assays (no added FABP) were performed in 
parallel for each concentration of each fatty acid. Radioactivity in a 
400.~1 aliquot of blank supernatant was subtracted from the amount of 
radioactivity present in a 400.~1 aliquot of FABP-containing supernatant. 
Net % bound cpm = 
2.875*FABP spn cpm 
total assay cpm 
2.875 *no FABP blank spn cpm - 
total assay cpm 1 [II 
where spn refers to supernatant and the constant 2.875 reflects the 
aliquot volume correction. The data were plotted as a Scatchard plot, 
with fatty acid concentration on the X axis, and “bound” over “free” 
on the Y axis. Bound is represented by net percentage bound cpm mul- 
tiplied by total picomoles of fatty acid in the assay. Free is total picomoles 
fatty acid in the assay minus bound picomoles fatty acid. 
Fluorescent fatty acid binding. Fluorescent ligand-binding measure- 
ments were carried out in a manner analogous to that described earlier 
for retinol binding to retinol-binding protein (24,25) with the following 
modifications. In a final volume of 2 ml the incubation mixture contained 
0.26-0.40 pM FABP and 0.1-10 pM cis- or trans-parinaric acid in 10 mM 
potassium phosphate buffer (pH 7.4). Each fatty acid concentration 
had an appropriate control without protein, the fluorescence intensity 
of which was subtract,ed from the total fluorescence. Fluorescence in- 
tensity was determined after a lo-min equilibration time. It was observed 
that all fluorescence changes were complete within this time period. 
Excitation was at 324 nm, using a 450-W Xe-Arc lamp as a light source 
in a SLM 4800 spectrofluorometer ( SLM Instruments, Champaign, IL). 
Fluorescence emission was recorded through a GG-375 sharp cutoff filter 
(Janos Technology Inc., Townshend, VT) in order to eliminate highly 
polarized scattered light. The instrument sensitivity was adjusted to the 
maximal intensity of the sample at the equilibrium condition. The 
ethanol concentration in the cuvette did not exceed 1%. 
Calculation of protein-ligand complex [EL]. The concentration of 
protein-ligand complex, free FABP, and free ligand were calculated from 
the fluorescence intensity changes (F) upon fluorescent fatty acid binding 
to FABP (25) applied as follows: In the concentration range O-3 pM 
absorbance at 324 nm of the samples was <0.15 O.D. At 5 and 10 pM 
fluorescent fatty acid, fluorescence intensity values were corrected for 
the inner filter effect. The total fluorescence for the cuvette with cis- or 
trans-parinaric acid and FABP is equal to 
F = fE[El + fdL1 + fEdELI 
and 
m = -fE[Eo - El - fL[Lo - Ll + f&ELI. 
Considering that 





where [E,] and [L,] are the total concentration of FABP and ligand, 
respectively; [E 1, [L] , and [EL] are concentration of free protein, free 
ligand, and FABP-ligand complex, respectively; fE, fL, and fEL are char- 
acteristic fluorescence signals for each parameter, respectively. Since fE 
at 324 nm is negligible ( fE < fL < fEL), 
[ELI = mI(fm - fL). [‘31 
The dissociation constant Kd can be expressed for a protein with one 
binding site (26) 
~=,T.,I(~~l)-IE,1(1-~). [71 
The saturated fraction, defined as [EL] / [ E,] , is equal to AF/AF,,,., . 
Upon substituting and rearranging, the following expression is obtained 
&l(l - (~I~rn,,)) = ([L,]/(AF/aF,,,)) - n[Eo]. [81 
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A plot of 1 / ( 1 - ( AF/ AF,, ) ) versus [ Lo] / ( AF/ AF,. ) is linear, where 
the abscissa intercept is [Es] and the slope is equal to 1 /Kd. Equations 
[ 71 and [ 81 were applied to the I-FABP binding equilibria which involves 
only one binding site. In the case of L-FABP, the presence of two fatty 
acid-binding sites were indicated by the radiolabeled competition binding 
studies, and so we applied an alternative, more general set of equations 
to examine the question of cooperativity. In the case of two binding 
sites, the total ligand concentration in the system is 
[LOI = [EL11 + 2lIGI + lL1 
and for the bound ligand, we can write 
191 
[LOI - lL1 = l&l + 21&l, 1101 
where [EL,] is the protein bound with one ligand, [ ELr] the protein 
with 2 ligands, and [Es] and [ Ls] are the total protein and ligand con- 
centrations, respectively. The fractional saturation (4) in the case of 
multiple binding sites can be described by the ratio of occupied sites to 
the total possible sites with the following assumptions: (i) The binding 
sites have similar K,,‘s. (ii) The quantum yield (Fb) is equal for each 
binding site. (iii) The fluorescence is additive when more than one 
binding site is occupied (i.e., no self-quenching between ligands). 
lJ%l + 21&l 
@J = 2([EL,] + [EL,] + [El) = 
[LoI - lL1 
21&l . 
The fraction of ligand bound ( f ) can described, 
1111 
f = [%I + 21&l 
[LOI . 
WI 
The relative fluorescence intensity of the sample (F,,) is the sum of 
the fluorescence yield of free ligand (Fr [ L] ) plus the fluorescence yield 
of both the partially and fully bound ligands, Fb ( [ ELiI + [EL,] ), 
(F,, - Fr[Ll)/Ft, = [EL,] + 2[EL2]. 1131 
The saturation of the binding sites can be described by ~5, the fractional 
saturation. 
9= 
Frel - Ff lL1 
Fb I 
2[Eol 
Replacing Eq. [13] into Eq. [ll] and multiplying by l/[ L,,] we obtain 
~ = Frd[bl - F,([LII[LI) 
2F[Eol ’ 
b rL1 
which can be reduced to 
f[Lol 
@J = 2[E,] ’ WI 
[I51 
The fractional saturation of the protein binding sites ( I#J) can be related 
in a straightforward manner (27) to the amount of free ligand [L] . 
+ lL1’ 
(l-@J) =x. ]I71 
The equation can be rearranged and put into logarithmic form to yield 
the familiar Hill plot 
+ log - = 
l-6 
log& +i WLI, 1181 
where j is the characterization factor of binding [j = 1, indicating single 
binding, j > 1, indicating positive cooperativity, and j < 1, indicating 
multiple binding or negative cooperativity, (27)] and Kd is the disso- 
ciation constant. In the L-FABP case a mean Kd value was used. 
Displacement offEuorescent fatty acids. The displacement of cis- and 
tram+parinaric acid by nonfluorescent fatty acids was determined using 
the percentage of the fluorescent intensity ratio, F/F,.,, where F rep- 
resents the fluorescence intensity observed when the competitor (non- 
fluorescent fatty acid) was present, and Fm, represents the observed 
fluorescence intensity in the absence of competing nonfluorescent fatty 
acid. The inhibitor constants, Ki, were determined from a nonlinear fit 
to a hyperbolic plot of F,,, - F versus the competitor concentration 
[ Li] , using the equation; (F,,,.. - F) = C*[Li]/(Ki + [Li]), where Ki 
is equal to [ Li] at F,../2, and C is a fitting constant equal to the best 
fit prediction of F,, . The fluorescence at each competitor concentration 
was measured in separate tubes after 10 min equilibration, and it was 
observed that all fluorescence changes were complete within this time 
period. 
RESULTS 
Radiolabeled Fatty Acid Binding 
A series of 18 carbon chain length of fatty acids with 
increasing number of double bonds was used to examine 
fatty acid binding to L-FABP and I-FABP. Both radio- 
labeled and fluorescent (see below) fatty acids were used. 
Radiolabeled fatty acid binding to FABPs was examined 
using the Lipidex-1000 method. The preference of L- 
FABP and I-FABP for binding of three radiolabeled fatty 
acids (stearic, oleic, and linoleic acid) containing 0, 1, 
and 2 double bonds, respectively, was determined. Mul- 
tiple assays ( n = 3-7) were performed with eight or more 
different fatty acid concentrations for each fatty acid. The 
results of the binding studies are presented as Scatchard 
plots in Fig. 1. Scatchard plots of stearic acid (Fig. 1A) , 
oleic acid (Fig. 1B ) , and linoleic acid (Fig. 1C ) binding 
to L-FABP or I-FABP were linear. Both FABPs exhibited 
saturable radiolabeled fatty acid binding, with affinities 
(I&) between 2.0 and 3.1 PM for I-FABP (Table I) and 
between 1.4 and 2.6 for L-FABP (Table II). The affinities 
of the L-FABP as compared to I-FABP for the same fatty 
acid (0, 1, or 2 double bonded) did not differ significantly 
(Table I versus Table II). However, L-FABP (Table I) 
and I-FABP (Table II) both showed a significantly (p 
< 0.05, n = 3-7) higher affinity for the unsaturated fatty 
acids, oleic acid, and linoleic acid, as compared to the 
saturated fatty acid, stearic acid. 
Fluorescent Fatty Acid Binding 
A fluorescent fatty acid-binding assay not requiring 
separation of FABP-bound from unbound fatty acid was 
developed. trans-Parinaric and cis-parinaric acid were 
chosen for this purpose because of the following proper- 
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FIG. 1. Scatchard analysis of the binding of radiolabeled fatty acids 
to I-FABP and L-FABP. Radiolabeled fatty acid binding to I-FABP 
(circles, lower line) and L-FABP (triangles, upper line) was measured 
by the Lipidex-1000 method as described under Materials and Methods: 
A, [1-‘*C]stearic acid (l&O) binding; B, [9,10-3H(N)]oleic acid 
(l&l) binding; C. [1-“C] linoleic acid (18:2) binding. Lines were fit to 
this data using the Graphpad (Institute of Scientific Information, Phil- 
adelphia, PA) linear regression program. In each panel values represent 
the mean (n = 3) at each fatty acid concentration. 
ties: (i) like the radiolabeled fatty acids in the preceding 
section, they are 18 carbon fatty acids, (ii) they are natural 
products, (iii) they do not contain bulky side chains, and 
(iv) they can be used as probes for saturated straight 
chain fatty acids (trans-parinaric acid) and unsaturated 
“kinked” chain fatty acids (cis-parinaric acid). The flu- 
orescence intensity of parinaric acids in aqueous solution 
is very weak. However, when bound to FABP the parinaric 
acids are excellent fluorophores (Fig. 2). Fluorescence 
intensity of bound trans-parinaric acid (Fig. 2A) and 
bound cis-parinaric acid (Fig. 2B ) increases with increas- 
ing fluorescent fatty acid concentration for both L-FABP 
and I-FABP. However, the maximum intensity of trans- 
parinarate fluorescence bound to L-FABP was 2.5 times 
that bound to I-FABP (Fig. 2A). In the case of cis-pari- 
naric acid the maximal fluorescence intensity in L-FABP 
was 3.4 times that in I-FABP. There was no indication 
of self-quench between the two parinaric acid molecules 
bound to L-FABP when either cis- or trans-parinaric acid 
was used. 
The higher maximal fluorescence intensity of the par- 
inaric acids when bound to L-FABP as compared to I- 
FABP could be due either to a difference in number and/ 
or affinity of binding sites, cooperativity between the 
binding sites (in the case of L-FABP) , or a difference in 
binding site environment. Radioligand-binding experi- 
ments described above showed that the L-FABP had two 
binding sites and the I-FABP had one binding site. Bind- 
ing curves for the fluorescent trans-parinaric acid and cis- 
parinaric acid to I-FABP (Fig. 3 ) and to L-FABP (Fig. 
4) were also consistent with two and one fatty acid-bind- 
ing sites, respectively. Thus a two-fold difference in num- 
ber of binding sites would account for a 2-fold, but not a 
2.5-fold (trans-parinaric acid) or a 3.4-fold (cis-parinaric 
acid), difference in fluorescence intensity of the same flu- 
orescent fatty acid bound to L-FABP versus I-FABP. The 
dissociation constants for the L-FABA bound fatty acids 
were so similar that separate values could not be deter- 
mined. Cooperativity between the two binding sites in L- 
FABP was examined as follows: The data in Fig. 2 support 
the idea that the maximum observed fluorescence change 
corresponds to complete occupation of the binding sites. 
Hill plots of the binding data provided values of (4) plot- 
ted in Fig. 4 which shows that the range of saturation 
shown as the change in (4) was between 0.9 (low occu- 
pancy) and 0.1 (close to complete saturation). The slope 
of these Hill plots (j) is the apparent order of the binding 
(see methods) which in both the case of cis- and trans- 
TABLE I 
Comparative Analysis of the Fatty Acid Binding Affinities 
of Delipidated, E. co&Derived I-FABP 
















3.1 k 0.34 1.03 + 0.18 (n = 5) 
2.07 f 0.27” 0.88 f 0.05 (n = 4) 
2.09 -t 0.17” 1.07 f 0.08 (n = 7) 
Fluorescent fatty acids 
cis-Parinaric Fluorescence 0.23 -r- 0.03”.* 0.96 + 0.23 (n = 4) 
acid Lipidex 0.38 0.9 
trans-Parinaric Fluorescence 0.66 f 0.19”J 1.19 f 0.07 (n = 4) 
acid Lipidex 1.04 1.05 
Note. The Lipidex-1000 assay and the fluorescence assay were used 
to determine the binding affinity of radiolabeled and fluorescent fatty 
acids to I-FABP as described under Materials and Methods. The values 
for B,.. were derived from the intercepts of the line in abscissa (Fig. 1 
for radiolabeled fatty acids; Fig. 3 for fluorescent fatty acids). The slopes 
of the lines were used to calculate affinities as described under Materials 
and Methods. Values represent the means f SEM (n = 3-7). 
‘p i 0.05 as compared to stearic acid. 
* p < 0.05 as compared to cis-parinaric acid. 
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TABLE II 
Comparative Analysis of the Fatty Acid-Binding Affinities 
of Delipidated, E. co&Derived L-FABP 
Radiolabeled fatty acids 
Fatty acids 
& B mex 
(FM) (PM FA/~M protein) 
from unbound fatty acid), essentially similar binding pa- 
rameters were obtained as with the fluorescence technique 
(not requiring separation of FABP-bound from unbound 
fatty acid). Thus, the greater number of double bonds 
appeared responsible for the tighter binding of the flu- 
orescent as compared to the radiolabeled fatty acids. 
Stearic acid (l&O) 
Oleic acid (l&l) 
Linoleic acid (l&2) 
2.59 + 0.24 1.79 + 0.25 
1.45 t- 0.23” 2.00 + 0.06 
1.93 f 0.13’ 1.27 + 0.11 
Fluorescent fatty acids 
& Hill slope 
cis-Parinaric acid 
trans-Parinaric acid 
0.72 f 0.065 0.485 
1.11 f 0.15 0.56 
Note. The Lipidex-1000 and fluorescence assays were used to deter- 
mine the binding affinity of radiolabeled and fluorescent fatty acids to 
L-FABP, respectively. The values for B,,,.. were derived from the inter- 
cepts of the line in abscissa (Fig. 1 for radiolabeled fatty acids; Fig. 4 
for fluorescent fatty acids). The slopes of the lines were used to calculate 
affinities as described under Materials and Methods. Values represent 
the means + SEM (n = 3 or 4). 
Basically similar observations were made with fluores- 
cent fatty acid binding to L-FABP as with I-FABP, with 
one exception. The L-FABP apparently bound two flu- 
orescent fatty acid molecules per molecule of L-FABP 
(Table II). Because of the presence of two fatty acid- 
binding sites in the L-FABP, the interaction of the flu- 
orescent fatty acids with L-FABP would be expected to 
result in maximal fluorescence intensity about 2-fold 
higher than binding by I-FABP. However, the measured 
fluorescence intensity of the tram- and cis-parinaric acids 
was 2.5- and 3.4fold higher in the L-FABP than in the 
I-FABP (Fig. 2). It is therefore apparent that these pro- 
teins differed not only in the number of binding sites but 
also in the properties of the binding site itself.” 
‘p < 0.05 as compared to stearic acid. I ’ , I 
parinaric acid was close to 0.5, implying that the multiple 
binding occurs without cooperativity. These data are con- 
sistent with the presence of only one fatty acid binding 
site in I-FABP, and two fatty acid binding sites in L- 
FABP. In addition, the environment of the fatty acid 
binding site in L-FABP differed significantly from that 
of I-FABP. 
The fluorescent cis- and trans-parinaric acids were used 
as structural model molecules for unsaturated and satu- 
rated fatty acids, respectively, in order to examine the 
fatty acid preference of I-FABP. ck-Parinaric and trans- 
parinaric acid bound to I-FABP with Kd’s of 0.23 and 
0.66 (p < 0.05), respectively, thereby confirming the 
preference of I-FABP for unsaturated (cis- double bonds) 
fatty acids noted above with the radiolabeled fatty acids 
(Table I). In addition, the fluorescent fatty acids both 
indicated the presence of only one binding site per I-FABP 
molecule. 
It is noteworthy that both of the fluorescent fatty acids 
were bound much more tightly to I-FABP (Table I) and 
L-FABP (Table II) than were any of the radiolabeled 
fatty acids. Since the chain length of the fluorescent and 
radiolabeled fatty acids was the same, the tighter binding 
was due either to a difference in assay procedures (Lip- 
idex-1000 versus fluorescence) or to the presence of four 
double bonds in the fluorescent fatty acids as compared 
to zero, one, or two double bonds in the radiolabeled fatty 
acids. As shown in Table I, when the binding of cis- or 
trans-parinaric acid to I-FABP was measured by the Lip- 
idex-1000 method (requiring separation of FABP-bound 
A 
.-. A 
50 - A / 
if 
50 0 2 
0, ’ I I 
1 5 10 
FATTY ACID (MM) 
FIG. 2. Interaction of fluorescent fatty acids with I-FABP and L- 
FABP. Binding of trans- (A) and ci.s- (B) parinaric acid to I-FABP 
(circles, bottom curve) and L-FABP (triangles, top curve) was monitored 
by increase in fluorescence intensity as described under Materials and 
Methods. 
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I I I I 
0 3 6 9 12 
Lo/(AF/AFmax) 
FIG. 3. Binding analysis of fluorescent fatty acids to I-FABP. truns- 
Parinaric acid (A) and cis- (B) parinaric acid binding to I-FABP was 
performed as shown in Fig. 2 and described under Materials and Methods. 
The data were transformed to linear least-square plots of l/( 1-AF/ 
AF-) vs [ L,, ] / ( AF/ AF,,,.. ) . The intercept on the abscissa is [ E,, ] and 
the slope is equal to 1 / Kd . Values indicated represent the mean ( n = 3 ) 
at each fatty acid concentration. 
Displacement of Bound cis- and trans-Parinaric by 
Nonfluorescent Fatty Acids 
Displacement of cis- and trans-parinaric acid bound to 
L-FABP and I-FABP was also used to study relative 
binding affinities of oleic and linoleic acid (Table III). 
When present in equimolar ratios (fluorescent/nonflu- 
orescent fatty acids), oleic and linoleic acid were more 
efficient in displacing both cis- and trans-parinaric acid 
from I-FABP than from L-FABP (Table III). This is 
expected since I-FABP and L-FABP contain one and two 
bound fluorescent fatty acids, respectively. The compe- 
tition with the nonfluorescent fatty acids of the binding 
of cis- or trans-parinaric acid for the I-FABP-binding site 
(Table IV) followed a similar trend as that found for L- 
FABP. Competition studies between the fluorescent fatty 
acids and stearic acid did not yield reliable data because 
of the very low solubility of the monomer in the assay 
conditions (ca. 2.5 PM), and the inability of stearic acid 
at this concentration to compete with the binding of the 
fluorescent fatty acid. 
DISCUSSION 
With few exceptions, comparative ligand binding stud- 
ies of FABPs have not been reported. Comparisons of 
relative &‘s and stoichiometries obtained in different 
laboratories are complicated by differences in assay 
methodology, source and purity of FABP, and the relative 
presence of endogenous bound ligand( s) , possibly ex- 
plaining the variation in reported affinities and stoichi- 
ometries. In an earlier study the Lipidex-1000 method 
was used to compare fatty acid binding to L-FABP versus 
I-FABP, a series of fatty acids varying both in degree of 
unsaturation and in fatty acid chain length were compared 
( 14). Such comparisons are, however, of limited value 
due to the dependence of fatty acid binding on chain 
length as well as unsaturation ( 11). In addition, the sep- 
aration process involved in the Lipidex 1000 assay may 
result in removal of weakly bound fatty acid, thereby low- 
ering the apparent number of fatty acid molecules bound 
as well as altering the Kd. In this assay, the FABP and 
fatty acid are incubated at 25°C resulting in an equilib- 
rium between FABP-bound and unbound fatty acid. The 
sample containing FABP-bound and unbound fatty acid 
is subsequently cooled to 0°C followed by addition of Lip- 
idex-1000. Thus, two factors could alter fatty acid binding 
characteristics in this method: First, at 0°C the fatty acid- 
FABP equilibrium may be perturbed. Second, the Lipidex- 
1000 and FABP compete for binding of free fatty acids. 
The implicit assumption with the Lipidex-1000 assay is 
that these possibilities are negligible. The Lipidex binding 
assay thus involves a set of competition equilibria between 

















0 1 2 
FIG. 4. Binding analysis of fluorescent fatty acids to L-FABP. trots- 
Parinaric acid (A) and cis- (B) parinaric acid binding to L-FABP was 
perfomed as described under Materials and Methods; data were collected 
as described in the legend to Fig. 2. The data were transformed using 
the form log(&/(l - 4)) vs log[L]. The slope of the curve, j, is the 
apparent order of the binding. Values indicated represent the mean (n 
= 3) at each fatty acid concentration. 
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TABLE III 
Displacement of I-FABP or L-FABP Bound Fluorescent cis- 
or truns-Parinaric Acid by Nonfluorescent Fatty Acids 
Displacement of fluorescent fatty acids (%) 




63.98 f 6.53 27.71 * 2.27 




13.46 + 2.69 22.04 -c 5.63 
11.82 k 1.65 11.34 f 1.38 
Note. Displacement of FABP bound cis- or trarzs-parinaric acid was 
determined as described under Materials and Methods. In each assay, 
concentrations were 0.4 pM FABP, 1 jtM cis- and trans-parinaric acid, 
and 1 pM fatty acid (ethanol 1%) in 2 ml 10 mM K-phosphate (pH 7.4). 
Displacement (decrease of fluorescence) is given as a percentage of the 
control fluorescence. Results are means of three experiments with SE. 
and as micelles) . There are also a number of factors such 
as the solubility of the ligand and its intrinsic affinity for 
Lipidex which can influence the value of the apparent 
binding constant. Thus the useful concentration range 
for this assay is limited. In this regard it is a clear advan- 
tage of the fluorescence assay that the equilibria involving 
the Lipidex are eliminated. Consequently in work pre- 
sented herein pure recombinant L-FABP and recombi- 
nant I-FABP were delipidated and binding of fatty acids 
was compared using a series of 18 carbon fatty acids and 
two independent binding assays. 
Number of Fatty Acid-Binding Sites 
in I-FABP and L-FABP 
The Lipidex-1000 fatty acid binding assay indicated 
that I-FABP has a single fatty acid-binding site. The flu- 
orescent trans- and cis-parinaric acid-binding assay con- 
firms this observation. These fatty acids also showed a 
single fatty acid-binding site in I-FABP. These obser- 
vations are consistent with results of others using a variety 
of techniques including NMR and X-ray diffraction ( 11, 
13, 14). 
In contrast to the general agreement on the number of 
fatty acid binding sites in I-FABP, there is considerable 
uncertainty for the L-FABP. The stoichiometry of fatty 
acid binding by L-FABP has been variously reported as 
1:l (11,15-19) or 2:1(9,14) and depends upon the phys- 
ical state of the unbound fatty acid and the sample pH 
(21). This uncertainty may be due in part to the use of 
fluorescent fatty acid analogues that contain bulky side 
chains, e.g., anthroyloxy, pyrene, or dansyl (17-19). It 
has been reported that fatty acids substituted with such 
bulky groups prevent binding of a second fatty acid to L- 
FABP (28). In contrast, as shown in the present inves- 
tigation, cis- and trans-parinaric acid used in a fluores- 
cence binding assay both indicate the presence of two 
fatty acid binding sites in L-FABP. cis-Parinaric and 
trans-parinaric acid are fluorescent fatty acids that do 
not contain bulky reporter groups. Instead, they contain 
a series of four conjugated double bonds as part of the 
methylene chain. 
The fluorescent fatty acids are also useful in regard to 
the tertiary orientation of the fatty acid-binding sites in 
the FABPs. Due to the presence of multiple binding sites 
in L-FABP the two fluorescent parinaric acid ligands 
could influence each other’s optical signals, either by 
quench, or by changes in the binding environment of one 
as a result of the occupancy of the second (38, 39). The 
data presented herein indicate that the two bound fatty 
acids do not quench each other. Fluorescence plateaued 
with increasing parinaric acid concentration. If quenching 
had occurred upon occupancy of the second binding site, 
a decrease in fluorescence would have been observed. 
Moreover, other investigators using anthroyl-labeled fatty 
acids also did not observe quenching when the L-FABP 
binding sites were saturated ( 19). Thus, the two fatty 
acids bound to L-FABP cannot occupy the same binding 
pocket of the protein and be arranged in parallel within 
that pocket. Thus, the two binding sites of L-FABP most 
likely have an orthogonal orientation and/or are physi- 
cally separated in the L-FABP. An earlier study using 
parinaric acid optical activity (circular dichroism) preli- 
minarily concluded that the fatty acids occupy the same 
binding site (9). However, it is not known if both binding 
sites were occupied by the fluorescent fatty acids under 
the conditions of the circular dichroism measurements. 
Last, there was no indication that the quantum yield dif- 
fers significantly between the fatty acids bound to the 
first site and that bound to the second. It is thus assumed 
(in Eq. [13] ) that the two fluorescence fatty acids are 
reporting independently on the occupancy of their re- 
spective binding sites. In support of this, the curve in Fig. 
TABLE IV 
Competitive Inhibition of Fluorescent Fatty Acid Binding by 
I-FABP by Nonfluorescent Fatty Acids 
K (FM) 
Ligand cis-Parinaric acid trans.Parinaric acid 
Oleic acid 0.39 f 0.09 1.46 + 0.40 
Linoleic acid 1.50 f 0.41 1.47 f 0.32 
Note. Competitive inhibition assays were performed in 2 ml K-phos- 
phate buffer (pH 7.4) containing 0.4 pM I-FABP, 1 pM cis- or truns- 
parinaric acid, and 0.1 to 5 fiM competitive inhibitor fatty acid. The 
inhibition of fluorescence intensity increase was measured. Inhibition 
constants (K,) were calculated from the F--F binding hyperbola. Values 
represent the means + SEM (n = 3). 
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2 shows a smooth concentration-dependent change upon 
the addition of either cis- or trans-parinaric acid, which 
is also consistent with close similarity of the quantum 
yields between the parinaric acid bound to the first and 
that bound to the second site. 
The possibility of conformational changes in the fatty 
acid-binding proteins as a result of fatty acid binding 
cannot be ruled out on the basis of the data reported 
herein. X-ray crystal data on I-FABP show that I-FABP 
does not undergo conformational change upon fatty acid 
binding ( 13). Similar data on the effect of fatty acid 
binding on L-FABP conformation are not yet available. 
Nevertheless, the data presented herein indicate that if 
conformational changes do occur in L-FABP upon fatty 
acid binding, they do not appear to influence the binding 
affinity for the second fatty acid ligand, and there is no 
indication that the quantum yield of the first bound mol- 
ecule of parinaric acid is influenced by the binding of the 
second. 
Comparative Fatty Acid-Binding Specificity of 
L-FABP and I-FABP 
As shown in the results section, two different binding 
assays using a series of 18 carbon radiolabeled (stearic, 
oleic, linoleic) or fluorescent (cis- and trans-parinaric) 
fatty acids indicated that I-FABP preferentially binds 
unsaturated fatty acids. The fatty acid binding affinities 
of I-FABP related to the number of double bonds were 4 
> 2 > 1 > 0. Most important, the fluorescence assay and 
the Lipidex-1000 assay (with either cis- or trans-parinaric 
acid) gave nearly identical results: the Kd’s and the stoi- 
chiometry of binding (0.23 pM and 1:l) were not signif- 
icantly different. This observation for the first time val- 
idates the Lipidex-1000 technique with a fluorescent 
technique that does not require separation of FABP bound 
fatty acid from unbound fatty acid. The only other re- 
ported study of the relative preference of I-FABP for spe- 
cific fatty acids also showed a higher Kd for I-FABP bind- 
ing the unsaturated fatty acid, oleate, as compared to the 
saturated fatty acid, palmitate. Interestingly, the fluores- 
cent fatty acids, cis- and trans-parinaric acid, bound more 
tightly to I-FABP than any of the other fatty acids tested. 
These data would lead to the prediction that arachidonic 
acid, a nonfluorescent fatty acid with four double bonds 
would also bind with very high affinity to I-FABP. Un- 
expectedly, arachidonic acid bound to I-FABP about as 
well as the saturated fatty acid palmitate (14). Possibly 
the conjugated versus nonconjugated nature of the double 
bonds in parinarate versus arachidonate can account for 
the difference in expected results. 
The fatty acid binding to L-FABP was investigated in 
a similar manner as for I-FABP. The L-FABP also showed 
a preferential binding for unsaturated fatty acids in the 
following order of double bonds: 4 > 2 > 1 > 0. This pref- 
erence for unsaturated fatty acids in in vitro assays is 
entirely consistent with results of some (14, 28, 29) but 
not all previous studies (11, 17, 30). Arachidonic acid 
( 14) and cis-parinaric acid were bound with higher affinity 
to L-FABP than saturated fatty acids. Interestingly, sev- 
eral reports showed the existence of an L-FABP isoform 
highly enriched in arachidonic acid ( 11, 31) . 
Competitive Fatty Acid Binding Specificity to 
I-FABP or L-FABP 
The preference of L-FABP and I-FABP for binding 
unsaturated fatty acids in vitro would lead to the predic- 
tion that these fatty acid-binding proteins should pref- 
erentially bind unsaturated fatty acids in vivo. Surpris- 
ingly, the composition of endogenous fatty acids bound 
to L-FABP and I-FABP expressed in E. coli growing at 
42°C showed that 70 and 100% of the endogenous fatty 
acids bound to L-FABP and I-FABP, respectively, were 
saturated (14). However, E. coli grown at 37°C contain 
only 15-36% c&unsaturated fatty acids ( 33)) and E. coli 
grown at 42°C are expected to contain even less cis-un- 
saturated fatty acids. The endogenous bound fatty acid 
composition will be determined by both the relative af- 
finities of these proteins for different fatty acids and the 
fatty acid milieu available for binding. Thus, the apparent 
discrepancy between these observations in vitro and the 
fatty acids bound endogenously (in vivo) to the L-FABP 
is explained by the much larger availability of saturated 
fatty acids in the E. coli. These findings are thus consistent 
with an approximately 1.5 to 2 times higher affinity for 
unsaturated fatty acids. In most cases a preponderance 
of unsaturated fatty acids is expected in mammalian tis- 
sues at 37°C. However, nutrition, endocrine, and other 
factors can affect this composition. 
On the basis of several reports indicating a relative 
preference of L-FABP and not I-FABP, for unsaturated 
fatty acids, earlier investigators postulated the I-FABP 
functions primarily in cytoplasmic transport of intestinal 
luminally derived fatty acid while L-FABP was involved 
in the transport of plasma-derived fatty acids ( 34, 35). 
However, the data presented herein showed similar pref- 
erence of L-FABP and I-FABP for unsaturated fatty ac- 
ids. In addition, immunohistochemical results of others 
(36) are also not consistent with this hypothesis. 
Structure of the Fatty Acid-Binding Site 
The tertiary structure of I-FABP and the binding of 
palmitate within this structure has been investigated ex- 
tensively ( 13,21,32). These investigators concluded that 
I-FABP has a clam shell-like structure with a 9 X 30-A 
gap forming the binding site that accommodates only a 
single fatty acid plus 7 solvent molecules (holo-I-FABP) 
or 13 solvent molecules in the absence of fatty acid (apo- 
I-FABP) ( 13, 32). The fatty acid, palmitate, assumed a 
bent configuration between carbon 2 and 3 with a left- 
handed helical conformation for the rest of the acyl chain. 
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The fluorophore of cis- and trans-parinaric acids is a rigid 
conjugated tetraene series of double bonds extending from 
carbon 9 to carbon 15. Thus, because they can still bend 
between carbons 2 and 3, the parinaric acids are both 
easily accommodated into the binding site of I-FABP. 
Although the binding of fluorescent fatty acids with bulky 
attached fluorophores to I-FABP has not been reported, 
the small size of the fatty acid-binding pocket of I-FABP 
[one saturated fatty acid plus about 7 solvent molecules, 
( 13 ) ] is expected to be insufficient for binding these bulky 
fatty acids. 
The tertiary structure of the fatty acid-binding site of 
L-FABP has not been reported. However, several obser- 
vations indicate that the structure ofthe fatty acid-binding 
sites in L-FABP may be quite different from that of I- 
FABP. First, the L-FABP fatty acid-binding site(s) ac- 
commodate( s) two rather than one fatty acid. Other data 
indicate that under some circumstances even a third fatty 
acid binding site may be accommodated in L-FABP ( 21) . 
Second, as pointed out earlier (26)) the fatty acid-binding 
site of L-FABP is unable to accommodate more than one 
fatty acid with a bulky fluorescence side chain. Third, in 
a recent study a complex induced circular dichroism for 
trans-parinaric acid bound to L-FABP was observed (37). 
These investigators concluded that L-FABP has two 
trans-parinaric acid molecules oriented in parallel in the 
same binding site. However, other investigators examining 
the structure of the phosphatidylcholine transfer protein 
phospholipid binding site showed that if the cis-parinaric 
acids attached to a phosphatidylcholine molecule were 
oriented in parallel self-quenching of fluorescence was 
observed (38,39). Fourth, the displacement experiments 
provided additional information that the L-FABP binding 
site(s) structurally can differ from that of I-FABP. Fifth, 
structural data indicate that the fatty acid carboxyl ter- 
minal is oppositely oriented in I-FABP (13, 21) and L- 
FABP ( 19,21) . 
In summary, the use of the fluorescent fatty acids, cis- 
and trans-parinaric acids, in conjunction with radiolabeled 
fatty acids and two independent binding assays has pro- 
vided valuable new information regarding the number of 
binding site(s), the fatty acid specificity of the binding 
site(s), and the structure of the binding site(s) in I-FABP 
and L-FABP. In addition, the simultaneous use of flu- 
orescent fatty acids in the Lipidex-1000 assay (requiring 
separation of bound from unbound fatty acid) and the 
fluorescence intensity assay (not requiring separation of 
bound from unbound fatty acid) and the close agreement 
between the results for the first time validates the Lipidex- 
1000 procedure used by many previous investigators. Last, 
the choice of cis- and trans-parinaric acid as fluorescent 
analogues of straight chain saturated and kinked chain 
unsaturated fatty acids provided data entirely consistent 
with those of the radiolabeled fatty acid-binding assay. 
The parinaric acids also proved to be much better flu- 
orescent fatty acid probe molecules than the bulky side 
chain-substituted fluorescent fatty acids since they gave 
the same number of binding sites as radiolabeled fatty 
acids for L-FABP. This was not the case with side chain- 
substituted fluorescent fatty acids used previously. 
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